Related Experiment Video
Updated: Mar 20, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
What timing of vaccination is potentially dangerous for children younger than 2 years?
Pauline Gras1, Anne-Charlotte Bailly1, Marion Lagrée1,2
1a Univ. Lille, CHU Lille, Pediatric Emergency Unit & Infectious Diseases , Lille , France.
Insights
Identifying dangerous vaccination delays is crucial for child health. This study defined critical timelines for vaccine doses to prevent disease, aiming to improve pediatric immunization effectiveness.
Area of Science:
- Pediatric Infectious Diseases
- Immunization Practices
- Public Health
Background:
- Vaccine-preventable diseases persist despite high coverage rates.
- Late or untimely vaccinations may contribute to disease occurrence in children.
- Defining safe vaccination windows is essential for effective public health strategies.
Purpose of the Study:
- To identify potentially dangerous vaccination delays for each vaccine dose in children under two years old.
- To establish consensus among experts on maximum acceptable delays for pediatric vaccinations.
- To inform future studies on vaccine effectiveness and improve childhood immunization quality.
Main Methods:
- A 3-round Delphi process involving 37 French pediatric vaccine experts.
- Literature review to generate items for 10 vaccine doses recommended before age two.
- A 70% consensus cutoff was used for item reduction and consensus building.
Main Results:
- Consensus was reached on maximum acceptable delays for 6 out of 10 vaccine doses.
- Specific delays were identified: 15 days for DTaP-IPV/Hib, 1 month for MenC, and by age 11 for HepB completion.
- These defined delays serve as critical indicators for vaccine timeliness.
Conclusions:
- The Delphi process successfully identified critical vaccination delays for children under two.
- These findings provide new indicators for assessing vaccine effectiveness and timeliness.
- Improving adherence to these vaccination schedules can enhance protection against preventable diseases in children.
Abstract:
Vaccine-preventable diseases still occur although measured coverage rates at 2 y of age are high. The occurrence of these diseases may be explained in part by untimely, that is, late vaccination. Our objective was to identify potentially dangerous vaccination delays for each dose of each vaccine in children younger than 2 y. A 3-round Delphi process was conducted by e-mail. We recruited 37 French experts in vaccines for children: 16 from the Infovac-France group and 21 from the French study group for pediatric infectious diseases. Items were generated by a literature review for the 10 vaccine doses recommended before 2 y of age. Item reduction in round 1 and 2 and any consensus in round 3 used a 70% consensus cutoff. The mean participation rate was 79%. Delays that should not be exceeded were identified for all vaccine doses. The 70% consensus was reached for 6 of the 10 vaccine doses: 15 d after the recommended date for the first 2 doses of the diphtheria-tetanus-acellular pertussis-inactivated polio vaccine/Haemophilus influenzae b vaccine and for the second dose of the pneumococcal conjugate vaccine, 1 month for the meningococcal C vaccine and for the first dose of the measles-mumps-rubella vaccine, and 11 y of age for completion of the hepatitis B vaccination. This Delphi process identified potentially dangerous vaccination delays for children to the age of 2 y. These can be used as new indicators in further studies of vaccine effectiveness and can help to improve the quality of vaccine protection in children.
Related Concept Videos
Vaccinations
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Vaccines
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Teratogenicity

